17,283 followers
Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits https://t.co/9rIYL2Trac https://t.co/qFI7RjYmqa
Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits https://t.co/9rIYL2Trac https://t.co/qFI7RjYmqa
New research: Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits: Background Patients with locally advanced prostate cancer (LAPCa) received docetaxel-based neoadjuvant… #oncology https://t.co/